MoneyTree Reports Overall Drop in Q1 Biotech VC Funding, But Smaller Declines in Boston and Bay Area Clusters

Silicon Valley remained the top US cluster with $210 million in first-quarter venture capital, down a little over 16 percent from the $251 million racked up a year earlier. New England's $149 million in biopharma VC marked a nearly 32 percent fall-off.